DUBLIN–(BUSINESS WIRE)–The “Optic Neuritis (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering.
This report provides comprehensive information on the therapeutics under development for Optic Neuritis (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Optic Neuritis pipeline guide also reviews of key players involved in therapeutic development for Optic Neuritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I and Preclinical stages are 1, 3 and 5 respectively. Similarly, the Universities portfolio in Phase II and Discovery stages comprises 1 and 1 molecules, respectively.
The guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Repot Scope:
- The pipeline guide provides a snapshot of the global therapeutic landscape of Optic Neuritis (Ophthalmology).
- The pipeline guide reviews pipeline therapeutics for Optic Neuritis (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Optic Neuritis (Ophthalmology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Optic Neuritis (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Optic Neuritis (Ophthalmology)
Companies Mentioned
- Accure Therapeutics SL
- EnhanX Biopharm Inc
- Japan Innovative Therapeutics Inc
- Meta-IQ ApS
- Mitochon Pharmaceuticals Inc
- Noveome Biotherapeutics Inc
- ReNetX Bio
-
SanBio Co Ltd
Key Topics Covered:
Introduction
Optic Neuritis – Overview
Optic Neuritis – Therapeutics Development
- Pipeline Overview
- Pipeline by Companies
- Pipeline by Universities/Institutes
- Products under Development by Companies
- Products under Development by Universities/Institutes
Optic Neuritis – Therapeutics Assessment
- Assessment by Target
- Assessment by Mechanism of Action
- Assessment by Route of Administration
- Assessment by Molecule Type
Optic Neuritis – Companies Involved in Therapeutics Development
- Accure Therapeutics SL
- EnhanX Biopharm Inc
- Japan Innovative Therapeutics Inc
- Meta-IQ ApS
- Mitochon Pharmaceuticals Inc
- Noveome Biotherapeutics Inc
- ReNetX Bio
- SanBio Co Ltd
Optic Neuritis – Drug Profiles
Optic Neuritis – Dormant Projects
Optic Neuritis – Discontinued Products
Optic Neuritis – Product Development Milestones
Featured News & Press Releases
For more information about this report visit https://www.researchandmarkets.com/r/am4dlh
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900